Premium
Venture capital firm Accel Partners has led an investment round in a US- and India-based drug discovery company focussed on cancer treatment, two people aware of the development told VCCircle.Accel, US-based venture capital firm Romulus Capital and financial services firm IIFL Holdings invested $9 million (Rs 60 crore) in Akamara ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
